Structural Characterization of Clusterin-Chaperone Client Protein Complexes *
Journal of Biological Chemistry, ISSN: 0021-9258, Vol: 284, Issue: 33, Page: 21920-21927
2009
- 71Citations
- 186Usage
- 66Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations71
- Citation Indexes71
- 71
- CrossRef58
- Usage186
- Downloads160
- Abstract Views26
- Captures66
- Readers66
- 66
Article Description
Clusterin (CLU) is a potent extracellular chaperone that inhibits protein aggregation and precipitation otherwise caused by physical or chemical stresses ( e.g. heat, reduction). This action involves CLU forming soluble high molecular weight (HMW) complexes with the client protein. Other than their unquantified large size, the physical characteristics of these complexes were previously unknown. In this study, HMW CLU-citrate synthase (CS), HMW CLU-fibrinogen (FGN), and HMW CLU-glutathione S -transferase (GST) complexes were generated in vitro, and their structures studied using size exclusion chromatography (SEC), ELISA, SDS-PAGE, dynamic light scattering (DLS), bisANS fluorescence, and circular dichroism spectrophotometry (CD). Densitometry of Coomassie Blue-stained SDS-PAGE gels indicated that all three HMW CLU-client protein complexes had an approximate mass ratio of 1:2 (CLU:client protein). SEC indicated that all three clients formed complexes with CLU ≥ 4 × 10 7 Da; however, DLS estimated HMW CLU-FGN to have a diameter of 108.57 ± 18.09 nm, while HMW CLU-CS and HMW CLU-GST were smaller with estimated diameters of 51.06 ± 6.87 nm and 52.61 ± 7.71 nm, respectively. Measurements of bisANS fluorescence suggest that the chaperone action of CLU involves preventing the exposure to aqueous solvent of hydrophobic regions that are normally exposed by the client protein during heat-induced unfolding. CD analysis indicated that, depending on the individual client protein, CLU may interact with a variety of intermediates on protein unfolding pathways with different amounts of native secondary structure. In vivo, soluble complexes like those studied here are likely to serve as vehicles to dispose of otherwise dangerous aggregation-prone misfolded extracellular proteins.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0021925818493982; http://dx.doi.org/10.1074/jbc.m109.033688; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=69249085727&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/19535339; https://linkinghub.elsevier.com/retrieve/pii/S0021925818493982; http://www.jbc.org/lookup/doi/10.1074/jbc.M109.033688; https://syndication.highwire.org/content/doi/10.1074/jbc.M109.033688; https://ro.uow.edu.au/scipapers/970; https://ro.uow.edu.au/cgi/viewcontent.cgi?article=2013&context=scipapers; https://dx.doi.org/10.1074/jbc.m109.033688; http://www.jbc.org/content/284/33/21920; http://www.jbc.org/article/S0021925818493982/abstract; http://www.jbc.org/article/S0021925818493982/fulltext; http://www.jbc.org/article/S0021925818493982/pdf; https://www.jbc.org/article/S0021-9258(18)49398-2/abstract; http://www.jbc.org/cgi/doi/10.1074/jbc.M109.033688; http://www.jbc.org/content/284/33/21920.abstract; http://www.jbc.org/content/284/33/21920.full; http://www.jbc.org/content/284/33/21920.full.pdf
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know